These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30612340)

  • 21. Mild cognitive impairment in Parkinson's disease is associated with decreased P300 amplitude and reduced putamen volume.
    Hünerli D; Emek-Savaş DD; Çavuşoğlu B; Dönmez Çolakoğlu B; Ada E; Yener GG
    Clin Neurophysiol; 2019 Aug; 130(8):1208-1217. PubMed ID: 31163365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The COMT val158met polymorphism and brain morphometry in healthy young adults.
    Zinkstok J; Schmitz N; van Amelsvoort T; de Win M; van den Brink W; Baas F; Linszen D
    Neurosci Lett; 2006 Sep; 405(1-2):34-9. PubMed ID: 16857316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.
    Li ML; Xiang B; Li YF; Hu X; Wang Q; Guo WJ; Lei W; Huang CH; Zhao LS; Li N; Ren HY; Wang HY; Ma XH; Deng W; Li T
    Neurosci Bull; 2015 Feb; 31(1):31-42. PubMed ID: 25564193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
    Hoogland J; de Bie RM; Williams-Gray CH; Muslimović D; Schmand B; Post B
    Mov Disord; 2010 Nov; 25(15):2550-4. PubMed ID: 20878993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SORL1 rs1699102 polymorphism modulates age-related cognitive decline and gray matter volume reduction in non-demented individuals.
    Li H; Lv C; Yang C; Wei D; Chen K; Li S; Zhang Z
    Eur J Neurol; 2017 Jan; 24(1):187-194. PubMed ID: 27779372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The enzymatic activities of brain catechol-O-methyltransferase (COMT) and methionine sulphoxide reductase are correlated in a COMT Val/Met allele-dependent fashion.
    Moskovitz J; Walss-Bass C; Cruz DA; Thompson PM; Hairston J; Bortolato M
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):941-51. PubMed ID: 25640985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume.
    Cerasa A; Gioia MC; Labate A; Liguori M; Lanza P; Quattrone A
    Neuroreport; 2008 Mar; 19(4):405-8. PubMed ID: 18287936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic contribution of catechol-O-methyltransferase in hippocampal structural and functional changes of female migraine sufferers.
    Liu J; Lan L; Mu J; Zhao L; Yuan K; Zhang Y; Huang L; Liang F; Tian J
    Hum Brain Mapp; 2015 May; 36(5):1782-95. PubMed ID: 25598522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.
    Lanni C; Garbin G; Lisa A; Biundo F; Ranzenigo A; Sinforiani E; Cuzzoni G; Govoni S; Ranzani GN; Racchi M
    J Alzheimers Dis; 2012; 32(4):919-26. PubMed ID: 22890094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Catechol-O-methyltransferase (COMT Val
    Almas A; Forsell Y; Millischer V; Möller J; Lavebratt C
    BMC Med Genet; 2018 Jul; 19(1):126. PubMed ID: 30045690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND; Jayathilake K; Meltzer HY
    Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant association between catechol-O-methyltransferase (COMT) Val
    Havelka Mestrovic A; Tudor L; Nikolac Perkovic M; Nedic Erjavec G; Kovacic Petrovic Z; Svob Strac D; Konjevod M; Pivac N
    Neurosci Lett; 2018 Feb; 666():38-43. PubMed ID: 29248614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
    Corvol JC; Bonnet C; Charbonnier-Beaupel F; Bonnet AM; Fiévet MH; Bellanger A; Roze E; Meliksetyan G; Ben Djebara M; Hartmann A; Lacomblez L; Vrignaud C; Zahr N; Agid Y; Costentin J; Hulot JS; Vidailhet M
    Ann Neurol; 2011 Jan; 69(1):111-8. PubMed ID: 21280081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethnic differences in COMT genetic effects on striatal grey matter alterations associated with childhood ADHD: A voxel-based morphometry study in a Japanese sample.
    Shimada K; Fujisawa TX; Takiguchi S; Naruse H; Kosaka H; Okazawa H; Tomoda A
    World J Biol Psychiatry; 2017 Jun; 18(4):322-328. PubMed ID: 26576742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment.
    Aracil-Bolaños I; Sampedro F; Marín-Lahoz J; Horta-Barba A; Martínez-Horta S; Botí M; Pérez-Pérez J; Bejr-Kasem H; Pascual-Sedano B; Campolongo A; Izquierdo C; Gironell A; Gómez-Ansón B; Kulisevsky J; Pagonabarraga J
    Hum Brain Mapp; 2019 Aug; 40(11):3233-3242. PubMed ID: 30938027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia.
    Neuhaus AH; Opgen-Rhein C; Urbanek C; Hahn E; Ta TM; Seidelsohn M; Strathmann S; Kley F; Wieseke N; Sander T; Dettling M
    Pharmacopsychiatry; 2009 Jul; 42(4):141-4. PubMed ID: 19585392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association study of a functional catechol-o-methyltransferase polymorphism and cognitive function in patients with dementia.
    Nedić G; Borovecki F; Klepac N; Mubrin Z; Hajnsek S; Nikolac M; Muck-Seler D; Pivac N
    Coll Antropol; 2011 Jan; 35 Suppl 1():79-84. PubMed ID: 21648315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.